Literature DB >> 19628316

Successful treatment with retinoids in patients with lupus nephritis.

Koji Kinoshita1, Kazuya Kishimoto, Hideki Shimazu, Yuji Nozaki, Masafumi Sugiyama, Shinya Ikoma, Masanori Funauchi.   

Abstract

Lupus nephritis is a major manifestation of systemic lupus erythematosus. Treatment with such immunosuppressive agents as corticosteroids or cyclophosphamide can decrease the progression of lupus nephritis; however, these agents have potentially severe adverse reactions. Therefore, the development of new drugs with fewer side effects is needed. Here, we report 2 patients with lupus that were treated successfully with retinoids. Initially, both patients were treated with 60 mg/d of prednisolone. However, nephrotic syndrome was not improved. Subsequently, treatment with 10 mg/d of all-trans-retinoic acid was started orally and elicited a good response, showing a decrease in proteinuria. Although additional controlled clinical studies are needed to confirm these findings, we suggest that therapy using retinoids may represent a novel approach to the treatment of patients with lupus nephritis. Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628316     DOI: 10.1053/j.ajkd.2009.06.012

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

1.  Dynamics of gut microbiota in autoimmune lupus.

Authors:  Husen Zhang; Xiaofeng Liao; Joshua B Sparks; Xin M Luo
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

2.  All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice.

Authors:  Michelle H Theus; Joshua B Sparks; Xiaofeng Liao; Jingjing Ren; Xin M Luo
Journal:  J Histochem Cytochem       Date:  2016-11-18       Impact factor: 2.479

Review 3.  Regulatory T Cells in SLE: Biology and Use in Treatment.

Authors:  Sophia Giang; Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

4.  Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans.

Authors:  Carla M Cuda; Shiwu Li; Shujuan Liang; Yiming Yin; Hari Hara S K Potula; Zhiwei Xu; Mayami Sengupta; Yifang Chen; Edward Butfiloski; Henry Baker; Lung-Ji Chang; Igor Dozmorov; Eric S Sobel; Laurence Morel
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

5.  Pin1-Targeted Therapy for Systemic Lupus Erythematosus.

Authors:  Shuo Wei; Nobuya Yoshida; Greg Finn; Shingo Kozono; Morris Nechama; Vasileios C Kyttaris; Xiao Zhen Zhou; George C Tsokos; Kun Ping Lu
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

Review 6.  Could retinoids be a potential treatment for rheumatic diseases?

Authors:  Yoshishige Miyabe; Chie Miyabe; Toshihiro Nanki
Journal:  Rheumatol Int       Date:  2014-06-18       Impact factor: 2.631

7.  Proteinuria impairs podocyte regeneration by sequestering retinoic acid.

Authors:  Anna Peired; Maria Lucia Angelotti; Elisa Ronconi; Giancarlo la Marca; Benedetta Mazzinghi; Alessandro Sisti; Duccio Lombardi; Elisa Giocaliere; Marialuisa Della Bona; Fabio Villanelli; Eliana Parente; Lara Ballerini; Costanza Sagrinati; Nicola Wanner; Tobias B Huber; Helen Liapis; Elena Lazzeri; Laura Lasagni; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 10.121

Review 8.  Retinoids: novel immunomodulators and tumour-suppressive agents?

Authors:  M R Carratù; C Marasco; G Mangialardi; A Vacca
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

9.  Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.

Authors:  Christoph Ruschil; Evelyn Dubois; Maria-Ioanna Stefanou; Markus Christian Kowarik; Ulf Ziemann; Marcus Schittenhelm; Markus Krumbholz; Felix Bischof
Journal:  Neurol Res Pract       Date:  2021-05-10

10.  Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.

Authors:  Xiaofeng Liao; Jingjing Ren; Cheng-Hsin Wei; A Catharine Ross; Thomas E Cecere; Bernard S Jortner; S Ansar Ahmed; Xin M Luo
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.